These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23635054)

  • 1. Clinical problem-solving. In the thick of it.
    Rao DA; Lakdawala NK; Miller AL; Loscalzo J
    N Engl J Med; 2013 May; 368(18):1732-8. PubMed ID: 23635054
    [No Abstract]   [Full Text] [Related]  

  • 2. Vortex Keratopathy: Fabry Related or Amiodarone Induced?
    Alp A; Akdam H
    Am J Cardiol; 2015 Sep; 116(5):826. PubMed ID: 26153877
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recent beginning atrial fibrillation].
    Andreu Rodríguez AL; Morillas Blasco P; García Aldabe JJ; Bertomeu Martínez V; Rodríguez Ortega JA
    Rev Clin Esp; 2004 Feb; 204(2):89-90. PubMed ID: 15023306
    [No Abstract]   [Full Text] [Related]  

  • 4. Enzyme replacement therapy with agalsidase beta in kidney transplant patients with Fabry disease: a pilot study.
    Mignani R; Panichi V; Giudicissi A; Taccola D; Boscaro F; Feletti C; Moneti G; Cagnoli L
    Kidney Int; 2004 Apr; 65(4):1381-5. PubMed ID: 15086478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary Screening Results of Fabry Disease in Kidney Transplantation Patients: A Single-Center Study.
    Yılmaz M; Uçar SK; Aşçı G; Canda E; Tan FA; Hoşcoşkun C; Çoker M; Töz H
    Transplant Proc; 2017 Apr; 49(3):420-424. PubMed ID: 28340804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the addition of atrial pacing to amiodarone reduce the incidence of postoperative atrial fibrillation: a pilot study.
    Shea J; Sodhi G; Najam F; Solomon AJ
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1752-3. PubMed ID: 24952821
    [No Abstract]   [Full Text] [Related]  

  • 7. Improvement of cardiac hypertrophy and ventricular function in a man with Fabry disease by treatment with recombinant alpha-galactosidase A.
    Komamura K; Higashi M; Yamada N
    Heart; 2004 Jun; 90(6):617. PubMed ID: 15145857
    [No Abstract]   [Full Text] [Related]  

  • 8. Kidney involvement in Anderson-Fabry disease.
    Meroni M; Sessa A; Battini G; Tazzari S; Torri Tarelli L
    Contrib Nephrol; 1997; 122():178-84. PubMed ID: 9399062
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiokeratomas in Fabry disease.
    Mutoh H; Konoshita T; Onoe T; Makino Y; Arakawa K; Nakamura H;
    Am J Med Sci; 2013 Oct; 346(4):302. PubMed ID: 22990047
    [No Abstract]   [Full Text] [Related]  

  • 10. What is the most common arrhythmia following cardiac revascularization?
    Kramer MJ; Ide B; Drew BJ
    Prog Cardiovasc Nurs; 1999; 14(4):159, 161. PubMed ID: 10689730
    [No Abstract]   [Full Text] [Related]  

  • 11. Amiodarone for the treatment of persistent atrial fibrillation.
    Noble SL; Replogle WH; Dickey SR
    J Fam Pract; 1999 May; 48(5):334-5. PubMed ID: 10334605
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-induced T wave alternans.
    Kaszala K; Kenigsberg DN; Krishnan SC
    J Cardiovasc Electrophysiol; 2006 Mar; 17(3):332. PubMed ID: 16643413
    [No Abstract]   [Full Text] [Related]  

  • 13. The kidney in Fabry's disease.
    Pisani A; Visciano B; Imbriaco M; Di Nuzzi A; Mancini A; Marchetiello C; Riccio E
    Clin Genet; 2014 Oct; 86(4):301-9. PubMed ID: 24645664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsense mutation in exon 2 of the alpha-galactosidase A gene in a patient with Fabry disease.
    Manni E; Fogli A; Baldinotti F; Rossi S; Funel N; Barachini P; Simi P
    Contrib Nephrol; 2001; (136):223-8. PubMed ID: 11688384
    [No Abstract]   [Full Text] [Related]  

  • 15. Amiodarone for atrial fibrillation.
    Zimetbaum P
    N Engl J Med; 2007 Mar; 356(9):935-41. PubMed ID: 17329700
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular outcomes in Fabry disease are linked to severity of chronic kidney disease.
    Talbot AS; Lewis NT; Nicholls KM
    Heart; 2015 Feb; 101(4):287-93. PubMed ID: 25381325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of new α-galactosidase A mutation responsible for Fabry disease: A case report.
    Battaglia Y; Scalia S; Rinaldi R; Storari A; Mignani R; Russo D; Duro G
    Clin Nephrol; 2019 Feb; 91(2):126-128. PubMed ID: 30474596
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of dronedarone and amiodarone on atrial fibrillatory rate in patients with persistent atrial fibrillation.
    John S; Salmas J; Kornej J; Löbe S; Stridh M; Sörnmo L; Hindricks G; Husser D; Bollmann A
    Int J Cardiol; 2013 Sep; 167(5):2354-6. PubMed ID: 23183245
    [No Abstract]   [Full Text] [Related]  

  • 19. First Reported Case of Fabry Disease Caused by a Somatic Mosaicism in the GLA Gene.
    Barriales-Villa R; Ochoa JP; Santomé-Collazo JL; Mosquera-Reboredo J; Cao-Vilariño M; Monserrat L
    Rev Esp Cardiol (Engl Ed); 2019 Jul; 72(7):585-587. PubMed ID: 30029973
    [No Abstract]   [Full Text] [Related]  

  • 20. Approach to management of atrial fibrillation in the Indian scenario.
    Vora A
    J Assoc Physicians India; 2007 Apr; 55 Suppl():30-2. PubMed ID: 18368864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.